{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:24:31Z","timestamp":1773325471305,"version":"3.50.1"},"reference-count":0,"publisher":"S. Karger AG","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatology"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1159\/000277928","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T11:50:18Z","timestamp":1264765818000},"page":"282-286","source":"Crossref","is-referenced-by-count":11,"title":["Infliximab for the Treatment of Refractory Adamantiades-Beh\u00e7et Disease with Articular, Intestinal, Cerebral and Ocular Involvement"],"prefix":"10.1159","volume":"220","author":[{"given":"Davide","family":"Donghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Mainetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","container-title":["Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.karger.com\/Article\/Pdf\/277928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T20:54:13Z","timestamp":1745441653000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000277928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1159\/000277928","relation":{},"ISSN":["1421-9832","1018-8665"],"issn-type":[{"value":"1421-9832","type":"electronic"},{"value":"1018-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}